ONCOVIR CANADA INC
$2,099,792.00
National Defence | Défense nationale
Innovation for Defence Excellence and Security Program
EF 2020-2021
Canada
The overall goal of this project is to advance the clinical development of Poly-ICLC (Hiltonol®), a broad-spectrum antiviral drug candidate, as an innovative solution to strengthen medical preparednes...